Back to search results

Contingency Management for Methamphetamine Use in Hawaii

This study is testing a program called Contingency Management (CM) to help people in Hawaii reduce methamphetamine use. CM offers positive reinforcement and small prizes when a urine test shows no methamphetamine. To join, you must be an adult (18 or older) who was hospitalized for a traumatic injury, tested positive for methamphetamine during that hospital stay, and have used methamphetamine weekly for at least six months. You also need to show at least moderate symptoms of Amphetamine-Type Substance Use Disorder. The researchers want to see how well CM works at 6 and 12 weeks after you start, and they will also ask about your experience with the program. The study plans to enroll 40 participants, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 40 participants.
What's involved
Participants will provide urine samples to test for methamphetamine. They will also participate in qualitative interviews after the program.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for outcomes at 6 and 12 weeks after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06532370

Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii

Recruiting
NAAges 18+InterventionalTreatment
Queen's Medical Center
~40 participants
Updated 2026-03-31 on ClinicalTrials.gov
What's tested:Contingency Managment

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
TEA Outcomes at 6 and 12-weeks
Measured over From enrollment to 6 and 12-weeks

Conditions

Contingency Managment
Methamphetamine Use Disorder

Explore related trials

Amphetamine-induced organic mental disorder

NCT06532370

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • The Queen's Medical Center

    Honolulu, Hawaiistudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Todd Seto, MD · STUDY_CHAIR · The Queens Medical Center

Who to contact

Nicholas R Schumann, Clinical Psychologist
[email protected]
(808) 691-7024
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Admitted trauma patients
Age greater than 18 years old
Urine drug screen positive for methamphetamines during the current hospitalization
Report at least weekly methamphetamine use
First methamphetamine use greater than 6 months prior to injury
Report at least 4 DSM-V Amphetamine-Type Substance Use Disorder symptoms (at least moderate disease)
Glasgow Coma Scale ≥13 upon arrival to the emergency department
Ability to understand and participate in study procedures
Ability to communicate in English

Exclusion

Active psychosis (reporting auditory or visual hallucinations)
Under ongoing cardiorespiratory monitoring
Evidence of moderate or severe traumatic brain injury
Patients who are known to be pregnant
Prisoner
Individuals incarcerated at the time of their hospitalization
Individuals lacking capacity to provide, or are otherwise unable or unwilling to provide written informed consent

What this trial measures

  • TEA Outcomes at 6 and 12-weeksFrom enrollment to 6 and 12-weeks

    Treatment Effectiveness Assessment (TEA): This assessment asks individuals to respond to changes in four domains following a drug treatment program: substance use, health, lifestyle, and community. The score for each domain can range from 1 (no change or not much) to 10 (much better), for a total score of 4-40. This score allows for the prioritization of each participants values, and therefore does not require strict abstinence to demonstrate benefit from drug treatment.